Literature DB >> 31196167

Influence of pathogen and focus of infection on procalcitonin values in sepsis: are there additional confounding factors?

Patrick M Honore1, David De Bels2, Rachid Attou2, Sebastien Redant2, Andrea Gallerani2, Kianoush Kashani3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31196167      PMCID: PMC6567478          DOI: 10.1186/s13054-019-2499-1

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
We read the study by Thomas-Rüddel et al. with great interest [1]. Authors showed serum procalcitonin (PCT) concentrations were higher in patients with Gram-negative bacteremia (26 ng/ml) than in those with Gram-positive bacteremia (7.1 ng/ml) or candidemia (P < .0001) [1]. They outlined some potential factors that could have impacted the PCT measurement outside to the type, location, and severity of the infection. In addition to their findings, it is essential to highlight that in patients with positive blood culture, septic shock is very common. Acute kidney injury (AKI) is prevalent among patients with sepsis, and a considerable proportion of patients with sepsis-associated AKI (SA-AKI) require renal replacement therapy (RRT) [2]. As PCT has an approximate molecular weight of 14.5 kDa [3], the contemporary continuous RRT membranes are able to remove it (CRRT cutoff is about 35 kDa) [4]. Also, using newer high adsorptive membranes (HAM) would make PCT removal even more prominent [4]. Accordingly, if in the study by Thomas-Rüddel et al., there was any imbalance between the uses of CRRT between the two groups, it could critically impact the observed results. We, therefore, suggest including the use of CRRT in the prediction model. In addition, the design of future studies to assess the performance of PCT among septic patients who are on CRRT seems to be necessary [5].
  5 in total

1.  Evaluating sepsis during continuous dialysis: are biomarkers still valid?

Authors:  Patrick M Honoré; Rita Jacobs; Elisabeth De Waele; Viola Van Gorp; Herbert D Spapen
Journal:  Blood Purif       Date:  2014-10-17       Impact factor: 2.614

Review 2.  An update on membranes and cartridges for extracorporeal blood purification in sepsis and septic shock.

Authors:  Patrick M Honoré; David De Bels; Herbert D Spapen
Journal:  Curr Opin Crit Care       Date:  2018-12       Impact factor: 3.687

3.  Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.

Authors:  Claude Level; Philippe Chauveau; Olivier Guisset; Marie Cécile Cazin; Catherine Lasseur; Claude Gabinsky; Stéphane Winnock; Danièle Montaudon; Régis Bedry; Caroline Nouts; Odile Pillet; Georges Gbikpi Benissan; Jean Claude Favarel-Guarrigues; Yves Castaing
Journal:  Crit Care       Date:  2003-10-02       Impact factor: 9.097

4.  Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia.

Authors:  Daniel O Thomas-Rüddel; Bernhard Poidinger; Matthias Kott; Manfred Weiss; Konrad Reinhart; Frank Bloos
Journal:  Crit Care       Date:  2018-05-13       Impact factor: 9.097

5.  A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit.

Authors:  Esther Peters; Massimo Antonelli; Xavier Wittebole; Rahul Nanchal; Bruno François; Yasser Sakr; Jean-Louis Vincent; Peter Pickkers
Journal:  Crit Care       Date:  2018-08-03       Impact factor: 9.097

  5 in total
  3 in total

Review 1.  [New predictive models of bacteremia in the emergency department: a step forward].

Authors:  A Julián-Jiménez; R Rubio-Díaz; J González Del Castillo; F J Candel
Journal:  Rev Esp Quimioter       Date:  2022-04-13       Impact factor: 2.515

2.  Effect of procalcitonin on the severity and prognostic value of elderly patients with a severe infection of oral and maxillofacial space.

Authors:  Xin-Yan Lin; Yu-Zhao Lin; Shao-Hua Lin; Jun-Jie Lian
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

3.  Prognostic values of procalcitonin and platelet in the patient with urosepsis.

Authors:  Ling Jiang; Shao-Hua Lin; Jun Wang; Cun-Kun Chu
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.